Skip to content

A Study on the Improvement of Tolerability and Comfort in Patients With Indwelling Endotracheal Tube After Oral and Maxillofacial Surgery with Different Doses of Dexmedetomidine Nasal Drops

A Study on the Improvement of Tolerability and Comfort in Patients With Indwelling Endotracheal Tube After Oral and Maxillofacial Surgery with Different Doses of Dexmedetomidine Nasal Drops

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500100618
Enrollment
Unknown
Registered
2025-04-11
Start date
2024-06-16
Completion date
Unknown
Last updated
2025-04-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients who require an indwelling endotracheal tube after oral and maxillofacial surgery

Interventions

Dexmedetomidine group (M1 group):Dexmedetomidine nasal drops (1ug/kg )
Dexmedetomidine group (M2 group):Dexmedetomidine nasal drops (1.5ug/kg )
Lidocaine (Group L):Instillation of 2% lidocaine hydrochloride injection through the endotracheal tube

Sponsors

Second Xiangya Hospital, Central South University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
30 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1: Indwelling nasotracheal tube should be > 24 hours after oral and maxillofacial surgery 2: ASA is graded as Class I or II 3: 30 years <= age <= 70 years

Exclusion criteria

Exclusion criteria: 1: Patients with tracheostomy 2: Patients with severe cardiovascular and cerebrovascular diseases or abnormalities of liver, kidney and other important organs 3: Combined with chronic respiratory diseases, such as chronic obstructive pulmonary disease or bronchial asthma 4: Patients with pre-existing respiratory infections before surgery 5: Those who have allergies to the test drugs and other adverse reactions 6: Patients with cognitive dysfunction before surgery 7: Unwilling to complete the test process or unable to understand the test process

Design outcomes

Primary

MeasureTime frame
Sore throat scored on a 4-point scale;

Secondary

MeasureTime frame
Frequency and severity of choking;Wound pain VAS score;Sedation-agitation score ;Postoperative satisfaction evaluation of patients;Hemodynamic parameters (systolic blood pressure, diastolic blood pressure, mean arterial pressure, heart rate);The number and amount of lidocaine remedy required for each group;Occurrence of delirium within 7 days after operation:;

Countries

China

Contacts

Public ContactFeng Xiao

Second Xiangya Hospital, Central South University

xiaofengcsu@csu.edu.cn+86 136 0743 0840

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026